After the Supreme Court’s decision in Prometheus and its vacatur and remand of the Myriad decision, the question of what constitutes patent eligible subject matter continues to pose a challenge to courts, the PTO and practitioners. This webinar will address the impact of the Prometheus decision on the eligibility question including what guidance it may provide with respect to the eligibility of gene patents, how the PTO is likely to react to the decision and the impact the decision will have on the medical field.Read more >
The itSMF USA ISO/IEC 20000 Special Interest Group is invites you to join the journey to “Destination ISO/IEC 20000”. During this third event the participants will learn about selecting an RCB, a Registered Certification Body, for ISO/IEC 20000 certification, and determining the goals and the scope and eligibility of the certification program.Read more >
Companion diagnostic tests are most commonly used to determine patient eligibility for specific therapies and are designed to ensure the therapy is administered safely to patients who are most likely to benefit. Thus, companion diagnostic tests are crucial in facilitating personalized healthcare for the individual patient. Join us as Keith Miller, FIBMS, Director of the United Kingdom National External Quality Assessment Scheme for Immunohistochemistry and In Situ Hybridisation (UKNEQAS-ICC&ISH), addresses the inherent risks in using laboratory developed tests as companion diagnostics, and the role of external quality assessment schemes (EQA) in helping laboratories monitor and maintain quality testing.Read more >
FOR FINANCIAL ADVISORS ONLY - NOT FOR GENERAL PUBLIC
How will your clients pay for college? Increasingly, families are looking to their trusted Financial Professional to assist them in developing a complete college funding strategy.
During this seminar we will cover essentials including:
- Understanding 529 benefits and financial aid impact
- Explaining the 4 types of financial aid
- Demystifying the financial aid eligibility calculation
- Five Steps to Successful Savings
We’ll distill the complicated world of scholarships, grants, work-study and student loans into the basics that every family needs
The Supreme Court’s June 28 decision in Bilski v Kappos saved the day for business methods, but has raised many questions as to how its principles will be applied in both prosecution and litigation going forward. Join LexisNexis and Managing IP on August 17 at 12:00pm EST to discuss what the ruling means for patent eligibility - specifically for inventions in the areas of biotechnology/ life sciences and financial services/ business methods - including strategies for success under the new standard.
The panel will include:
Eric Bensen, Author and Consultant
Laurie Axford, Partner, The Nath Law Group
Ankur Shah, Associate General Counsel, Freddie Mac
Attend this seminar and get answers to questions regarding the 2015/2016 employer mandate:
How does eligibility relate to the employer mandate?
Employer size - 50 and over, 100 and over?
How do I calculate full time equivalent workers?
What do I need to know about affordability and minimum value?
Reporting requirements. What are they?
How will potential penalties and tax provisions affect my organization?
Are you an intensive energy user? Would you like to know more about the government's consultation on the eligibility for exemption from upcoming Contracts for Difference (CfD) costs and compensation for the costs of FiT and RO? Join npower and BIS, the government department designing the scheme, to find out more and give BIS your feedback directly.
If you're not an intensive energy user you might still want to sign up and learn more as the CfD exemptions are set to add further cost for other consumers.
In Part 1, we shared key trends to watch and consider as you build your mobile plan for 2014. In this session, we take a deeper dive to help you develop your company's mobile policy to fully embrace the BYOD trend, enable employees to be productive on any device they choose, and keep corporate data secure.
Watch Ovum analyst, Richard Absalom, as he outlines Ovum's 6 recommended areas to consider when building a mobility policy:
- Security: Safeguarding corporate-sensitive data
- Employee privacy: Defining clear boundaries between monitoring corporate and personal usage
- Eligibility: Identifying which employees are suitable for your policy
- Acceptable use and dealing with policy violations: Educating users to comply with policy regulations
- Technical support: Determining responsibility for dealing with device malfunctions
- Reimbursement and total cost of ownership: Drawing the line for corporate expenses
Many patients around the world struggle to gain access to new therapeutic options. There may be no clinical trials in close proximity or the eligibility requirements are too limiting. In some cases the wait for approval may simply be too long.
In such cases a Global Access Program can be an effective way to ensure the medicine reaches the patient. These programs (also referred to as expanded access, compassionate use and named patient programs) follow ethical and regulatory-compliant mechanisms, enabling patients to gain access to medicines that are in clinical development, are unlicensed in a specific market but licensed elsewhere, or are still going through the marketing authorization application (MAA) process.
These programs afford companies the opportunity to meet ethical obligations, offering physicians and patients potentially life-saving or life-extending treatment options, ahead of commercial availability. In addition, Global Access Programs can assist in helping foster positive relationships with key opinion leaders and treatment centres, as well as providing an opportunity to gather limited, yet valuable, information about the use of a drug in a wider population.
This free webinar will provide an overview of Global Access Programs and the current regulatory environment, describe best practices for implementation and present a case study detailing use of such programs to help patients with unmet medical needs.
Please join us on December 4, 3pm Europe, 2pm UK time.
- Paul Ledger, Head of Commercialisation for EMAP Rare Disease for GSK
- Mark Corbett, Senior Vice President, Clinigen Global Access Programs (GAP)
Payroll World Live in conjunction with award-winning payroll provider Ceridian presents a free webinar on pensions auto-enrolment.
Find out everything you need to know about AE and ask any of your questions directly to payroll pensions experts.
Areas covered will include:
-What to expect from your pension provider (and what not to!)
-Pay reference periods
-Assessment and eligibility
The Texas Office of the Attorney General’s Crime Victim Services Division provides victims of violent crimes a means to apply for eligibility for the Crime Victims’ Compensation Program, which pays medical and other bills related to the crime.
Dated system was close to failure, which would have negatively impacted victim’s claim processing as well as legislative mandated measures, putting federal funding in jeopardy.
Work unpredictability was burdensome to existing system of manual processes.
Implementation & Innovation
Initiates pre-defined and ad hoc tasks, with email or workflow notifications supporting work unpredictability
Provides for improved reporting, content analytics and trend analyses relative to the nature of the crime victim services required
Starts cases without all required information, allowing the jumpstart of an investigation
Leverages business rules to drive the assignment of cases, including staff availability, case type, and degree of relatedness
Enhances the speed and quality of case outcomes by tailoring work to the way Knowledge Workers worked
Improves allocation and utilization of resources because the system provides a 360 degree view of the work processes and workload status
Offers better reliability, security and lower long term operating cost through cloud-hosting
Platform approach lends itself to next phases: mainframe replacement and social networking
IBM Business Partner – Adjacent Technologies Inc.
IBM Case Manager platform